These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 20131015

  • 1. Downstaging without complete pathologic response after neoadjuvant treatment improves cancer outcomes for cIII but not cII rectal cancers.
    de Campos-Lobato LF, Stocchi L, da Luz Moreira A, Kalady MF, Geisler D, Dietz D, Lavery IC, Remzi FH, Fazio VW.
    Ann Surg Oncol; 2010 Jul; 17(7):1758-66. PubMed ID: 20131015
    [Abstract] [Full Text] [Related]

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 3. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H, Shmueli E, Figer A, Klausner JM, Rabau M.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2661-7. PubMed ID: 18389322
    [Abstract] [Full Text] [Related]

  • 4. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.
    Cance WG, Carey LA, Calvo BF, Sartor C, Sawyer L, Moore DT, Rosenman J, Ollila DW, Graham M.
    Ann Surg; 2002 Sep 01; 236(3):295-302; discussion 302-3. PubMed ID: 12192316
    [Abstract] [Full Text] [Related]

  • 6. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW.
    Int J Radiat Oncol Biol Phys; 2004 Nov 15; 60(4):1098-105. PubMed ID: 15519780
    [Abstract] [Full Text] [Related]

  • 7. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):665-77. PubMed ID: 15708244
    [Abstract] [Full Text] [Related]

  • 8. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK, Baik SH, Seong JS, Kim H, Roh JK, Lee KY, Sohn SK, Cho CH.
    Ann Surg; 2006 Dec 01; 244(6):1024-30. PubMed ID: 17122629
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.
    Ceelen W, Boterberg T, Pattyn P, van Eijkeren M, Gillardin JM, Demetter P, Smeets P, Van Damme N, Monsaert E, Peeters M.
    Ann Surg Oncol; 2007 Feb 01; 14(2):424-31. PubMed ID: 17096057
    [Abstract] [Full Text] [Related]

  • 10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 11. Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy?
    Kuo LJ, Liu MC, Jian JJ, Horng CF, Cheng TI, Chen CM, Fang WT, Chung YL.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2766-72. PubMed ID: 17551794
    [Abstract] [Full Text] [Related]

  • 12. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK.
    Ann Thorac Surg; 2006 Aug 01; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [Abstract] [Full Text] [Related]

  • 13. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Wolff RA, Eng C, Krishnan S, Janjan NA, Crane CH.
    Cancer; 2007 May 01; 109(9):1750-5. PubMed ID: 17387743
    [Abstract] [Full Text] [Related]

  • 14. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
    Zhan T, Gu J, Li M, Du C.
    Dis Colon Rectum; 2013 Apr 01; 56(4):422-32. PubMed ID: 23478609
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BD.
    Am Surg; 2005 Jun 01; 71(6):487-92. PubMed ID: 16044927
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.
    Valentini V, Coco C, Rizzo G, Manno A, Crucitti A, Mattana C, Ratto C, Verbo A, Vecchio FM, Barbaro B, Gambacorta MA, Montoro C, Barba MC, Sofo L, Papa V, Menghi R, D'Ugo DM, Doglietto G.
    Surgery; 2009 May 01; 145(5):486-94. PubMed ID: 19375606
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.
    Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):99-107. PubMed ID: 18407433
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation.
    de Campos-Lobato LF, Dietz DW, Stocchi L, Vogel JD, Lavery IC, Goldblum JR, Skacel M, Pelley RJ, Kalady MF.
    Colorectal Dis; 2012 Jan 01; 14(1):62-7. PubMed ID: 21176057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.